BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 8412313)

  • 41. Rearrangement of T-cell receptor delta/gamma genes: application to the study of clonality in childhood B-lineage acute lymphoblastic leukaemia.
    Januszkiewicz D; Nowak J
    Acta Haematol Pol; 1994; 25(3):277-81. PubMed ID: 7992601
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of antigen receptor gene rearrangements in lymphoproliferative malignancies by fluorescent polymerase chain reaction.
    Kerlan-Candon S; Soua Z; Lefranc MP; Clot J; Eliaou JF
    Tissue Antigens; 1998 Jan; 51(1):20-9. PubMed ID: 9459500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T-cell acute lymphoblastic leukemia.
    Neale GA; Pui CH; Mahmoud HH; Mirro J; Crist WM; Rivera GK; Goorha RM
    Leukemia; 1994 May; 8(5):768-75. PubMed ID: 8182934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia.
    Dibenedetto SP; Lo Nigro L; Mayer SP; Rovera G; Schilirò G
    Blood; 1997 Aug; 90(3):1226-32. PubMed ID: 9242556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minimal residual disease in acute lymphoblastic leukaemia--PCR analysis of immunoglobulin gene rearrangements.
    Cole-Sinclair M; Foroni L; Wright F; Mehta A; Prentice HG; Hoffbrand AV
    Leuk Lymphoma; 1993; 11 Suppl 2():49-58. PubMed ID: 8124233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction.
    Brisco MJ; Condon J; Hughes E; Neoh SH; Sykes PJ; Seshadri R; Toogood I; Waters K; Tauro G; Ekert H
    Lancet; 1994 Jan; 343(8891):196-200. PubMed ID: 7904666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.
    Bader P; Hancock J; Kreyenberg H; Goulden NJ; Niethammer D; Oakhill A; Steward CG; Handgretinger R; Beck JF; Klingebiel T
    Leukemia; 2002 Sep; 16(9):1668-72. PubMed ID: 12200679
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of minimal residual disease in T-cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapse.
    Neale GA; Menarguez J; Kitchingman GR; Fitzgerald TJ; Koehler M; Mirro J; Goorha RM
    Blood; 1991 Aug; 78(3):739-47. PubMed ID: 1859886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rearrangement and diversification of T-cell receptor delta genes in acute lymphoblastic leukemia.
    Griesinger F; Grümayer ER; Van Ness B; Kersey JH
    Leukemia; 1992 Oct; 6(10):1054-62. PubMed ID: 1328776
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitation of leukemia clone-specific antigen gene rearrangements by a single-step PCR and fluorescence-based detection method.
    Mayer SP; Giamelli J; Sandoval C; Roach AS; Fevzi Ozkaynak M; Tugal O; Rovera G; Jayabose S
    Leukemia; 1999 Nov; 13(11):1843-52. PubMed ID: 10557060
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of T-cell receptor delta gene rearrangement by clonal specific polymerase chain reaction.
    Chan DW; Liang R; Chan V; Kwong YL; Chan TK
    Leukemia; 1997 Apr; 11 Suppl 3():281-4. PubMed ID: 9209365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in immunoglobulin heavy chain gene rearrangmeent patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leaukemia at diagnosis.
    Beishuizen A; Verhoeven MA; Hählen K; van Wering ER; van Dongen JJ
    Leukemia; 1993 Jun; 7(6):60-3. PubMed ID: 8315958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Profile of immunoglobulin heavy chain variable gene repertoires and highly selective detection of malignant clonotypes in acute lymphoblastic leukemia.
    Greenberg SJ; Choi Y; Ballow M; Du TL; Ward PM; Rickert MH; Frankel S; Bernstein SH; Brecher ML
    J Leukoc Biol; 1995 Jun; 57(6):856-64. PubMed ID: 7790768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IgH/TCR delta PCR oligonucleotide liquid hybridization, a fast and sensitive assay for monitoring minimal residual disease in childhood B-precursor ALL.
    Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; Behrendt H; von dem Borne AE; van der Schoot CE
    Leukemia; 1995 Jan; 9(1):216-22. PubMed ID: 7845021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monitoring of adult B-cell lineage acute lymphoblastic leukemia: validation of a simple method for detecting immunoglobulin heavy chain gene clonality.
    Salo A; Pakkala S; Jansson SE; Helminen P; Palotie A
    Leukemia; 1993 Sep; 7(9):1459-65. PubMed ID: 8371595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late relapsing childhood lymphoblastic leukemia.
    Vora A; Frost L; Goodeve A; Wilson G; Ireland RM; Lilleyman J; Eden T; Peake I; Richards S
    Blood; 1998 Oct; 92(7):2334-7. PubMed ID: 9746771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation of bone marrow minimal residual disease and apparent isolated extramedullary relapse in childhood acute lymphoblastic leukaemia.
    O'Reilly J; Meyer B; Baker D; Herrmann R; Cannell P; Davies J
    Leukemia; 1995 Apr; 9(4):624-7. PubMed ID: 7723395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kinetics of minimal residual disease during induction/consolidation therapy in standard-risk adult B-lineage acute lymphoblastic leukemia.
    Scholten C; Födinger M; Mitterbauer M; Laczika K; Mitterbauer G; Haas OA; Knöbl P; Schwarzinger I; Thalhammer R; Purtscher B
    Ann Hematol; 1995 Oct; 71(4):155-60. PubMed ID: 7578520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CDR3 size analysis of T cell receptor V beta transcripts: follow-up study in a patient with T cell acute lymphoblastic leukemia.
    Prevost-Blondel A; Ostankovitch M; Melle J; Pannetier C; Macintyre E; Dreyfus F; Guillet JG
    Leukemia; 1995 Oct; 9(10):1711-7. PubMed ID: 7564515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Minimal residual disease quantification in childhood acute lymphoblastic leukemia by real-time polymerase chain reaction using the SYBR green dye.
    Li AH; Forestier E; Rosenquist R; Roos G
    Exp Hematol; 2002 Oct; 30(10):1170-7. PubMed ID: 12384148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.